1-(3-astatobenzyl)guanidine has been researched along with (4-fluoro-3-iodobenzyl)guanidine in 1 studies
Studies (1-(3-astatobenzyl)guanidine) | Trials (1-(3-astatobenzyl)guanidine) | Recent Studies (post-2010) (1-(3-astatobenzyl)guanidine) | Studies ((4-fluoro-3-iodobenzyl)guanidine) | Trials ((4-fluoro-3-iodobenzyl)guanidine) | Recent Studies (post-2010) ((4-fluoro-3-iodobenzyl)guanidine) |
---|---|---|---|---|---|
11 | 0 | 2 | 7 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Larsen, RH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
1 other study(ies) available for 1-(3-astatobenzyl)guanidine and (4-fluoro-3-iodobenzyl)guanidine
Article | Year |
---|---|
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Binding Sites; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Neuroblastoma; Tissue Distribution; Tumor Cells, Cultured | 1997 |